![Robert Hof](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Robert Hof currently works at Symeres BV, as Managing Director from 2020 and Syncom BV, as Chief Operating Officer.
Aktive Positionen von Robert Hof
Unternehmen | Position | Beginn |
---|---|---|
Syncom BV
![]() Syncom BV Miscellaneous Commercial ServicesCommercial Services Syncom BV is a contract research organization that specializes in all aspects of organic synthesis. Syncom focuses on synthetic chemistry support for mainly medicinal chemistry and chemical development groups. Areas of expertise include asymmetric synthesis, vitamin D and steroid syntheses and heterocyclic chemistry. Dutch resolution is a unique technology used for resolution of racemates by means of diastereomeric salt formation. Chirality in general is specialty of Syncom. About 90% of te current work is done for the pharmaceutical industry and the other 10% for companies interested in materials including organic semiconductors and film components. Syncom is privately owned and was incorporated in 1988. | Geschäftsführer | 06.05.2011 |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Corporate Officer/Principal | 01.03.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Syncom BV
![]() Syncom BV Miscellaneous Commercial ServicesCommercial Services Syncom BV is a contract research organization that specializes in all aspects of organic synthesis. Syncom focuses on synthetic chemistry support for mainly medicinal chemistry and chemical development groups. Areas of expertise include asymmetric synthesis, vitamin D and steroid syntheses and heterocyclic chemistry. Dutch resolution is a unique technology used for resolution of racemates by means of diastereomeric salt formation. Chirality in general is specialty of Syncom. About 90% of te current work is done for the pharmaceutical industry and the other 10% for companies interested in materials including organic semiconductors and film components. Syncom is privately owned and was incorporated in 1988. | Commercial Services |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |